TAUNS Laboratories,Inc. Income Statement

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Revenue	19,671	18,435	15,673
Revenue Growth (YoY)	-	17.62%	-
Cost of Revenue	5,798	5,937	6,473
Gross Profit	13,873	12,498	9,200
Selling, General & Admin	4,315	4,045	3,819
Operating Expenses	4,738	4,468	4,233
Operating Income	9,135	8,030	4,967
Interest Expense	-77.56	-31.21	-21.81
Interest & Investment Income	13.55	7.69	7.47
Other Non Operating Income (Expenses)	-182.98	-165.95	0.51
EBT Excluding Unusual Items	8,888	7,841	4,953
Gain (Loss) on Sale of Investments	-1.67	-1.67	-297.85
Gain (Loss) on Sale of Assets	0.22	-6.16	-0.74
Other Unusual Items	0.06	1.89	-
Pretax Income	8,886	7,835	4,655
Income Tax Expense	2,373	2,061	1,620
Net Income	6,513	5,774	3,035
Net Income to Common	6,513	5,774	3,035
Net Income Growth	-	90.26%	-
Shares Outstanding (Basic)	101	100	100
Shares Outstanding (Diluted)	113	107	100
Shares Change (YoY)	-	6.94%	-
EPS (Basic)	64.45	57.74	30.35
EPS (Diluted)	57.77	53.99	30.35
EPS Growth	-	77.90%	-
Free Cash Flow	-	6,182	-4,247
Free Cash Flow Per Share	-	57.80	-42.47
Dividend Per Share	16.650	10.650	-
Gross Margin	70.53%	67.80%	58.70%
Operating Margin	46.44%	43.56%	31.69%
Profit Margin	33.11%	31.32%	19.36%
Free Cash Flow Margin	-	33.53%	-27.10%
EBITDA	-	8,706	5,607
EBITDA Margin	-	47.23%	35.78%
D&A For EBITDA	-	676.16	639.97
EBIT	9,135	8,030	4,967
EBIT Margin	46.44%	43.56%	31.69%
Effective Tax Rate	26.71%	26.30%	34.80%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.